Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.055 CAD | +10.00% | +10.00% | -15.38% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- One of the major weak points of the company is its financial situation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-15.38% | 10.74M | - | ||
+4.26% | 104B | A- | ||
-5.63% | 63.11B | A- | ||
+40.95% | 39.72B | B | ||
+10.00% | 36.58B | B | ||
+4.84% | 32.8B | A- | ||
+6.01% | 19.26B | B- | ||
+11.51% | 16.66B | C+ | ||
+18.30% | 15.23B | B- | ||
+5.60% | 14.74B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- GDNP Stock
- Ratings good natured Products Inc.